Centre of Medical Information Science, Kochi Medical School, Kochi University, Nankoku, Japan.
Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Nankoku, Japan.
Nephrology (Carlton). 2021 Apr;26(4):312-318. doi: 10.1111/nep.13831. Epub 2021 Jan 9.
To clarify the effects of the duration of acute damage and/or loss of renal function following an acute kidney injury event on the renal prognosis after recovery.
We retrospectively reviewed data collected between 1995 and 2016 from the Kochi Medical School Hospital. Patients were stratified according to the time required for recovery with fluid therapy (expected to reflect the presence of renal dysfunction): ≤2 days after onset, transient injury group (n = 491); 3 to 7 days after onset, persistent injury group (n = 1076); and ≥ 8 days after onset, acute kidney disease group (n = 1046). The healthy group comprised 1000 randomly selected adult patients without acute kidney injury with at least two creatinine measurement results during the study. Survival time was defined as the time from recovery to a 30% decrease in the estimated glomerular filtration rate (primary endpoint). Kaplan-Meier and Cox proportional hazards analyses were conducted.
Event incidence rates were higher for the transient injury, persistent injury and acute kidney disease groups than for the healthy group. Persistent injury and acute kidney disease presented a higher risk of renal function decline than transient injury following recovery.
Transient acute kidney injury, persistent acute kidney injury and acute kidney disease resulted in functional decline and rapid chronic kidney disease progression risks despite recovery. Transient acute kidney injury recovery within 2 days could be associated with better long-term prognoses than persistent acute kidney injury and acute kidney disease persisting beyond 2 days.
阐明急性肾损伤(AKI)事件后急性损伤和/或肾功能丧失持续时间对恢复后肾脏预后的影响。
我们回顾性分析了 1995 年至 2016 年期间来自高知医科大学医院的数据。根据液体治疗恢复所需的时间(预计反映肾功能障碍的存在)对患者进行分层:发病后≤2 天,短暂性损伤组(n=491);发病后 3 至 7 天,持续性损伤组(n=1076);发病后≥8 天,急性肾脏病组(n=1046)。健康组包括 1000 名随机选择的在研究期间至少有两次肌酐测量结果的无 AKI 的成年患者。生存时间定义为从恢复到估算肾小球滤过率(eGFR)下降 30%的时间(主要终点)。进行 Kaplan-Meier 和 Cox 比例风险分析。
短暂性损伤、持续性损伤和急性肾脏病组的事件发生率高于健康组。与短暂性损伤相比,持续性损伤和急性肾脏病在恢复后肾功能下降的风险更高。
尽管恢复,但短暂性 AKI、持续性 AKI 和急性肾脏病仍可导致功能下降和快速慢性肾脏病进展风险。在 2 天内恢复的短暂性 AKI 可能与持续性 AKI 和持续时间超过 2 天的急性肾脏病相比具有更好的长期预后。